Blog / Archives
BIO International Conference June 6-9 in San Francisco Next Week
BIO International Conference-Trends in the Biotechnology Industry We will be attending BIO International Convention in San Francisco next week and will provide news updates on relevant topics such...
NantHealth (NH) IPO Prices at $14 Moves Up To $18+…Update-1
Update -1 NH closes at $18.59 up 32.79% on volume of 3.3M shares. High was $21 low was $16.11. Market cap is $2.1B. Focus of the Company is personalized healthcare utilizing a unique software...
Biotech Rally Moving Toward April Highs: ASCO and M&A Provides Underlying Support…Update-1
Update June 1... After Close Biotech Holds...Uh oh CNBC is talking about biotech. IBB 281.18, XBI 58.18 This stealth rally has been going steady for two weeks but now CNBC and its "Fast Money" show...
Biotech Rally Fades But Plenty of Big Movers: ASCO June 6
Biotech Rally Fades after Five Days: IBB down 0.49%, XBI down 1% Biotech stocks were weak at the onset and could not come back but the sector is still up about 7% over five days. Stocks were mixed...
Healthcare Sector Is Looking A Tad Better: M&A Boosts Biotech…Update-1
Update-1 "Growthier" market move sparked by housing data-new home sales jump 16.6% A broad rally today surprised many traders. Technology was a leader up 2% followed by healthcare up 1.49%. US new...
Nothing New To Report: Green Screen Day…Update-1
Update: M&A will come back-- Pfizer (PFE) buys Anacor (ANAC) for $5.2B. Now you see why inversions are not good for biotech stocks as PFE had to give up reverse merger and go for growth. ...
On Vacation this week
Will try to post by weekend. Thank you for reading. IBB down 3% to 256. 5/11/16
Large Cap Biopharmaceuticals Q1 2016 Metrics: Earnings Show Limited Growth Prospects
Large Cap Biopharma Winners and Losers -Looking for Product Growth We will sift through these metrics and new product news over the coming months to find value in these names. Most should be...
Biotech Bear Market: Another Bad Day IBB Down 2.9%…Update-1 Regeneron (REGN)
Update-1 May 5 ...Biotechs Stable Today...IBB up 0.45%, XBI down 0.53% Regeneron Pharmaceuticals (REGN) up 4.74% on sales growth,but missed on EPS. Regeneron (REGN) raised 2016 sales estimates for...
Failed Biotech Rally: Latest Biotech Earnings Don’t Help…ALXN AMGN CELG GILD…Update-1
Update-1 May 2 Biotechs Stop Slide...IBB up 1.12%...Green Screen Day Healthcare Stocks Regain Footing... XLV up 0.57% Biotech stocks moved up after a five day swoon but are still flat after one...